Long-term cognitive and neurochemical effects of "bath salt" designer drugs methylone and mephedrone - PubMed (original) (raw)
Long-term cognitive and neurochemical effects of "bath salt" designer drugs methylone and mephedrone
Bjørnar den Hollander et al. Pharmacol Biochem Behav. 2013 Jan.
Abstract
Introduction/aims: The use of cathinone-derivative designer drugs methylone and mephedrone has increased rapidly in recent years. Our aim was to investigate the possible long-term effects of these drugs on a range of behavioral tests in mice. Further, we investigated the long-term effects of these drugs on brain neurochemistry in both rats and mice.
Methods: We treated animals with a binge-like regimen of methylone or mephedrone (30 mg/kg, twice daily for 4 days) and, starting 2 weeks later, we performed behavioral tests of memory, anxiety and depression and measured brain levels of dopamine (DA), serotonin (5-HT), their metabolites and norepinephrine (NE). 5-HT and DA transporter (5-HTT and DAT) levels were also measured in rats by [(3)H]paroxetine and [(3)H]mazindol binding.
Results: Mephedrone reduced working memory performance in the T-maze spontaneous alternation task but did not affect neurotransmitter levels aside from a 22% decrease in striatal homovanillic acid (HVA) levels in mice. Methylone had little effect on behavior or neurotransmitter levels in mice but produced a widespread depletion of 5-HT and 5-HTT levels in rats.
Conclusions: Both methylone and mephedrone appeared to have a long-term effect on either behavioral or biochemical gauges of neurotoxicity in rodents.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
- Serotonergic impairment and memory deficits in adolescent rats after binge exposure of methylone.
López-Arnau R, Martínez-Clemente J, Pubill D, Escubedo E, Camarasa J. López-Arnau R, et al. J Psychopharmacol. 2014 Nov;28(11):1053-63. doi: 10.1177/0269881114548439. Epub 2014 Sep 18. J Psychopharmacol. 2014. PMID: 25237120 - The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue.
Baumann MH, Ayestas MA Jr, Partilla JS, Sink JR, Shulgin AT, Daley PF, Brandt SD, Rothman RB, Ruoho AE, Cozzi NV. Baumann MH, et al. Neuropsychopharmacology. 2012 Apr;37(5):1192-203. doi: 10.1038/npp.2011.304. Epub 2011 Dec 14. Neuropsychopharmacology. 2012. PMID: 22169943 Free PMC article. - Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM. Deltheil T, et al. Neuropharmacology. 2008 Nov;55(6):1006-14. doi: 10.1016/j.neuropharm.2008.08.001. Epub 2008 Aug 12. Neuropharmacology. 2008. PMID: 18761360 Review. - Designer psychostimulants: pharmacology and differences.
Iversen L, White M, Treble R. Iversen L, et al. Neuropharmacology. 2014 Dec;87:59-65. doi: 10.1016/j.neuropharm.2014.01.015. Epub 2014 Jan 20. Neuropharmacology. 2014. PMID: 24456744 Review.
Cited by
- Mephedrone (4-Methylmethcathinone): Acute Behavioral Effects, Hyperthermic, and Pharmacokinetic Profile in Rats.
Šíchová K, Pinterová N, Židková M, Horsley RR, Lhotková E, Štefková K, Vejmola Č, Uttl L, Balíková M, Kuchař M, Páleníček T. Šíchová K, et al. Front Psychiatry. 2018 Jan 10;8:306. doi: 10.3389/fpsyt.2017.00306. eCollection 2017. Front Psychiatry. 2018. PMID: 29375408 Free PMC article. - Cognitive deficits and neurotoxicity induced by synthetic cathinones: is there a role for neuroinflammation?
Leyrer-Jackson JM, Nagy EK, Olive MF. Leyrer-Jackson JM, et al. Psychopharmacology (Berl). 2019 Mar;236(3):1079-1095. doi: 10.1007/s00213-018-5067-5. Epub 2018 Oct 27. Psychopharmacology (Berl). 2019. PMID: 30368582 Free PMC article. Review. - Repeated doses of methylone, a new drug of abuse, induce changes in serotonin and dopamine systems in the mouse.
López-Arnau R, Martínez-Clemente J, Abad S, Pubill D, Camarasa J, Escubedo E. López-Arnau R, et al. Psychopharmacology (Berl). 2014 Aug;231(16):3119-29. doi: 10.1007/s00213-014-3493-6. Epub 2014 Apr 5. Psychopharmacology (Berl). 2014. PMID: 24705904 - Is the 3,4-methylendioxypyrovalerone/mephedrone combination responsible for enhanced stimulant effects? A rat study with investigation of the effect/concentration relationships.
Benturquia N, Chevillard L, Poiré C, Roussel O, Cohier C, Declèves X, Laplanche JL, Etheve-Quelquejeu M, Chen H, Mégarbane B. Benturquia N, et al. Psychopharmacology (Berl). 2019 Mar;236(3):891-901. doi: 10.1007/s00213-018-4962-0. Epub 2018 Jul 3. Psychopharmacology (Berl). 2019. PMID: 29971461 - Mitochondrial respiratory dysfunction due to the conversion of substituted cathinones to methylbenzamides in SH-SY5Y cells.
den Hollander B, Sundström M, Pelander A, Siltanen A, Ojanperä I, Mervaala E, Korpi ER, Kankuri E. den Hollander B, et al. Sci Rep. 2015 Oct 14;5:14924. doi: 10.1038/srep14924. Sci Rep. 2015. PMID: 26462443 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical